Biochip technology for monitoring posttraumatic stress disorder (PTSD)

Biochip Journal

Volumn 7, Issue 3, 2013, Pages 195-200

  Lee, Jung Hyun ^a   Jung, Hyo Il ^a  

^a Yonsei University   (South Korea)

Author keywords

biochip; biomarkers; Posttraumatic stress disorder (PTSD)

Indexed keywords

BIOCHIPS; BIOMARKERS; BODY FLUIDS; DIAGNOSIS; PATIENT TREATMENT;

BIOCHIP TECHNOLOGIES; BIOLOGICAL MARKERS; MICRO-FABRICATION TECHNIQUES; MOLECULAR LINKERS; NEW APPLICATIONS; POSTTRAUMATIC STRESS DISORDER; SUBJECTIVE ASSESSMENTS; TRAUMATIC EVENTS;

DISEASES;

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; AMYLASE; BIOLOGICAL MARKER; CD63 ANTIGEN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; NEURON SPECIFIC ENOLASE; NEUROPEPTIDE Y; PADGEM PROTEIN; PRASTERONE SULFATE; PROTEIN S100B; SEROTONIN;

BIOCHIP; BLOOD ANALYSIS; CORTISOL DEHYDROEPIANDROSTERONE SULFATE RATIO; DISEASE CLASSIFICATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; GENE; HEART RATE; HEMISPHERIC DOMINANCE; HORMONE DETERMINATION; HUMAN; LATENT PERIOD; LEFT HANDEDNESS; LEUKOCYTE COUNT; MEASUREMENT ACCURACY; METABOLIC PARAMETERS; MICROFLUIDIC ANALYSIS; MICROTECHNOLOGY; PAPER; PATIENT MONITORING; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; REM SLEEP; REVIEW; SALIVA ANALYSIS; SURFACE PLASMON RESONANCE; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; URINALYSIS; WFS1 GENE;

EID: 84884510820     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-013-7301-x     Document Type: Review

References (58)

1. Ursano, R. J. et al. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. The American Journal of Psychiatry161, 3-31 (2004).
2. Zhang, L. et al. Identification of gene markers based on well validated and subcategorized stressed animals for potential clinical applications in PTSD. Medical Hypotheses66, 309-314 (2006).
3. McGall, G. H. et al. The Efficiency of Light-Directed Synthesis of DNA Arrays on Glass Substrates. Journal of American Chemical Society119, 5081-5090 (1997).
4. Berrade, L., Garcia, A. E. & Camarero, J. A. Protein Microarrays: Novel Developments and Applications. Pharmaceutical Research28, 1480-1499 (2011).
5. El-Ali, J., Sorger, P. K. & Jensen, K. F. Cells on chips. Nature442, 403-411 (2006).
6. Harrison, D. J. et al. Micromachining a Miniaturized Capillary Electrophoresis-Based Chemical Analysis System on a Chip. Science261, 895-897 (1993).
7. Lee, J. H., Hwang, Y., Cheon, K. A. & Jung, H. I. Emotion-on-a-chip (EOC): Evolution of biochip technology to measure human emotion using body fluids. Medical Hypotheses79, 827-832 (2012).
8. Singh, I. & Rose, N. Biomarkers in psychiatry. Nature460, 202-207 (2009).
9. Lemieux, A., Coe, C. L. & Carnes, M. Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment. Brain, Behavior, Immunity22, 994-1003 (2008).
10. Rosen, G. M. & Lilienfeld, S. O. Posttraumatic stress disorder: an empirical evaluation of core assumptions. Clinical Psychology Review28, 837-868 (2008).
11. Boscarino, J. A. Psychobiologic predictors of disease mortality after psychological trauma: implications for research and clinical surveillance. The Journal of Nervous and Mental Disease196, 100-107 (2008).
12. von Kanel, R. et al. Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder. Psychiatry Research158, 363-373 (2008).
13. Song, Y., Zhou, D., Guan, Z. & Wang, X. Disturbance of serum interleukin-2 and interleukin-8 levels in posttraumatic and non-posttraumatic stress disorder earthquake survivors in northern China. Neuroimmunomodulation14, 248-254 (2007).
14. Kovacic, Z. et al. Platelet serotonin concentration and suicidal behavior in combat related posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry32, 544-551 (2008).
15. Pivac, N. et al. Platelet serotonin in combat related posttraumatic stress disorder with psychotic symptoms. Journal of Affective Disorders93, 223-227 (2006).
16. Muck-Seler, D. et al. Platelet 5-HT concentration and comorbid depression in war veterans with and without posttraumatic stress disorder. Journal of Affective Disorders75, 171-179 (2003).
17. Spivak, B. et al. Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biological Psychiatry45, 840-845 (1999).
18. Pivac, N. et al. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder. Journal of Affective Disorders103, 131-138 (2007).
19. Meewisse, M. L. et al. Cortisol and post-traumatic stress disorder in adults: systematic review and metaanalysis. The British Journal of Psychiatry191, 387-392 (2007).
20. Ehlert, U., Gaab, J. & Heinrichs, M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biological Psychology57, 141-152 (2001).
21. Heber, R., Kellner, M. & Yehuda, R. Salivary cortisol levels and the cortisol response to dexamethasone before and after EMDR: a case report. Journal of Clinical Psychology58, 1521-1530 (2002).
22. Glover, D. A. & Poland, R. E. Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology27, 805-819 (2002).
23. Yehuda, R., Halligan, S. L. & Bierer, L. M. Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child. Psychoneuroendocrinology27, 171-180 (2002).
24. Gotovac, K. et al. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clinical & Experimental Immunology131, 335-339 (2003).
25. Kesner, Y. et al. WFS1 gene as a putative biomarker for development of post-traumatic syndrome in an animal model. Molecular Psychiatry14, 86-94 (2009).
26. Vidovic, A. et al. Baseline level of platelet-leukocyte aggregates, platelet CD63 expression, and soluble Pselectin concentration in patients with posttraumatic stress disorder: a pilot study. Psychiatry Research150, 211-216 (2007).
27. Sojka, P., Stalnacke, B. M., Bjornstig, U. & Karlsson, K. One-year follow-up of patients with mild traumatic brain injury: occurrence of post-traumatic stress-related symptoms at follow-up and serum levels of cortisol, S-100B and neuron-specific enolase in acute phase. Brain Injury20, 613-620 (2006).
28. Dutton, M. A., Lee, E. W. & Zukowska, Z. NPY and extreme stress: lessons learned from posttraumatic stress disorder. NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics95, 213-222 (2006).
29. Boscarino, J. A. Psychobiologic predictors of disease mortality after psychological trauma: implications for research and clinical surveillance. The Journal of Nervous and Mental Disease196, 100-107 (2008).
30. Baker, D. G. et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation9, 209-217 (2001).
31. Maes, M. et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental manmade traumatic events. Biological Psychiatry45, 833-839 (1999).
32. Reist, C. et al. REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry19, 433-443 (1995).
33. Kauffman, C. D., Reist, C., Djenderedjian, A., Nelson, J. N. & Haier, R. J. Biological markers of affective disorders and posttraumatic stress disorder: a pilot study with desipramine. Journal of Clinical Psychiatry48, 366-367 (1987).
34. Pitman, R. K. et al. Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Annals of the New York Academy of Sciences1071, 242-254 (2006).
35. Bryant, R. A., Salmon, K., Sinclair, E. & Davidson, P. Heart rate as a predictor of posttraumatic stress disorder in children. General Hospital Psychiatry29, 66-68 (2007).
36. Chemtob, C. M. & Taylor, K. B. Mixed lateral preference and parental lefthandedness: possible markers of risk for PTSD. The Journal of Nervous and Mental Disease191, 332-338 (2003).
37. Atmaca, M. et al. Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder. European Archives of Psychiatry and Clinical Neuroscience252, 161-165 (2002).
38. Vaiva, G. et al. Relationship between posttrauma GABA plasma levels and PTSD at 1-year follow-up. The American Journal of Psychiatry163, 1446-1448 (2006).
39. Wang, Q. et al. Alterations of myelin basic protein and ultrastructure in the limbic system at the early stage of trauma-related stress disorder in dogs. The Journal of Trauma56, 604-610 (2004).
40. Sondergaard, H. P., Hansson, L. O. & Theorell, T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clinica Chimica Acta342, 93-98 (2004).
41. Glover, D. A. & Poland, R. E. Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology27, 805-819 (2002).
42. Garrison, R. L. & Breeding, P. C. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Medical Hypotheses61, 182-189 (2003).
43. Kibler, J. L., Joshi, K. & Ma, M. Hypertension in relation to posttraumatic stress disorder and depression in the US National Comorbidity Survey. The Journal of Behavioral Medicine34, 125-132 (2009).
44. Falconer, E. M. et al. Developing an integrated brain, behavior and biological response profile in posttraumatic stress disorder (PTSD). Journal of Integrative Neuroscience7, 439-456 (2008).
45. Bryant, R. A. et al. A multisite study of initial respiration rate and heart rate as predictors of posttraumatic stress disorder. Journal of Clinical Psychiatry69, 1694-1701 (2008).
46. Hamner, M. B. & Gold, P. B. Plasma dopamine betahydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Research77, 175-181 (1998).
47. Geuze, E. et al. Reduced GABA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Molecular Psychiatry13, 74-83 (2008).
48. Zhang, L. et al. A strategy for the development of biomarker tests for PTSD. Medical Hypotheses73, 404-409 (2009).
49. Baker, D. G., Nievergelt, C. M., & O'Connor, D. T. Biomarkers of PTSD: Neuropeptides and immune signaling. Neuropharmacology62, 663-673 (2012).
50. Su, T. P. et al. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. Journal of Psychiatric Research43, 1078-1085 (2009).
51. Zhang, L. et al. Identification of gene markers based on well validated and subcategorized stressed animals for potential clinical applications in PTSD. Medical Hypotheses66, 309-314 (2006).
52. Hellhammer, D. H., Wüst, S. & Kudielka, B. M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology34, 163-171 (2009).
53. Lee, H. J. et al. A planar split-ring resonator-based biosensor for label-free detection of biomolecules. Sensors and Actuators B: Chemical169, 26-31 (2012).
54. Mitchell, J. S., Lowe, T. E. & Ingram, J. R. Rapid ultrasensitive measurement of salivary cortisol using nanolinker chemistry coupled with surface plasmon resonance detection. Analyst134, 380-386 (2009).
55. Whitesides, G. M. The origins and the future of microfluidics. Nature442, 368-373 (2006).
56. Buchanan, T., Bibas, D. & Adolphs, R. Salivary α-amylase levels as a biomarker of experienced fear. Communicative and Integrative Biology3, 525-527 (2010).
57. Yamaguchi, M. et al. Hand-held monitor of sympathetic nervous system using salivary amylase activity and its validation by driver fatigue assessment. Biosensors and Bioelectronics21, 1007-1014 (2006).
58. Martinez, A. W., Phillips, S. T. & Whitesides, G. M. Diagnostics for the developing World: Microfluidic paper-based analytical devices. Analytical Chemistry82, 3-10 (2010).